The family phaselicystidaceae

The Prokaryotes: Deltaproteobacteria and Epsilonproteobacteria

Volumn 9783642390449, Issue , 2014, Pages 239-245

  Garcia, Ronald ^a   Müller, Rolf ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930239801     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-39044-9_307     Document Type: Chapter

References (28)

1. Behrens J, Flossdorf J, Reichenbach H(1976) Base composition of deoxyribonucleic acid from Nannocystis exedens(Myxobacterales). Int J Syst Bacteriol 26:561-562
2. Bode H, Müller R(2006) Analysis of myxobacterial secondary metabolism goes molecular. J Ind Microbiol Biotechnol 33:577-588
3. Bode H, Müller R(2008) Secondary metabolism in myxobacteria. In: Whitworth DE(ed) Myxobacteria: multicellularity and differentiation. ASM Press, Washington, DC, pp 259-282
4. Calder P(2001) Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36:1007-1024
5. Drews G(1974) Mikrobiologisches Praktikum, 2nd edn. Springer, Berlin
6. Fan YY, Chapkin R(1998) Importance of dietary g-linolenic acid in human health and nutrition. J Nutr 128:1411-1414
7. Fudou R, Jojima Y, Iizuka T, Yamanaka S(2002) Haliangium ochraceum gen. nov. sp. nov. And Haliangium tepidum sp. nov.: novel moderately halophilic myxobacteria isolated from coastal saline environments. J Gen Appl Microbiol 48:109-116
8. Garcia RO, Krug D, Müller R(2009a) Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods. In: Hopwood D(ed)Methods in enzymology: complex enzymes in microbial natural product biosynthesis, part A, vol 458. Academic, Burlington, pp 59-91
9. Garcia RO, Reichenbach H, Ring MW, Müller R(2009b) Phaselicystis flava gen. nov. sp. nov. An arachidonic acid-containing soil myxobacterium, and the description of Phaselicystidaceae fam. nov. Int J Syst Evol Microbiol 59:1524-1530
10. Garcia R, Gerth K, Stadler M, Dogma IJ Jr, Müller R(2010) Expanded phylogeny of myxobacteria and evidence for cultivation of the 'unculturables'. Mol Phylogenet Evol 57:878-887
11. Garcia R, Pistorius D, Stadler M, Müller R(2011) Fatty acid-related phylogeny of myxobacteria as an approach to discover polyunsaturated omega-3/6 fatty acids. J Bacteriol 193:1930-1942
12. Gerth K, Pradella S, Perlova O, Beyer S,Müller R(2003)Myxobacteria: proficient producers of novel natural products with various biological activities-past and future biotechnological aspects with the focus on the genus Sorangium. J Biotechnol 106:233-253
13. Horrocks L, Yeo Y(1999) Health benefits of docosahexaenoic acid(DHA). Pharmacol Res 40:211-225
14. Kopp M, Irschik H, Gross F, Perlova O, Sandmann A, Gerth K, Müller R(2004) Critical variations of conjugational DNA transfer into secondary metabolite multiproducing Sorangium cellulosum strains So ce12 and So ce56: development of a mariner-based transposon mutagenesis system. J Biotechnol 107:29-40
15. Mohr KI, Garcia R, Gerth K, Irschik H,Müller R(2012) Sandaracinus amylolyticus gen. nov. sp. nov. A starch-degrading soil myxobacterium, and description of Sandaracinaceae fam. nov. Int J Syst Evol Microbiol 62:1191-1198
16. Reichenbach H(2001) Myxobacteria, producers of novel bioactive substances. J Ind Microbiol Biotechnol 27:149-156
17. Reichenbach H, Höfle G(1993) Biologically active secondary metabolites from myxobacteria. Biotechnol Adv 11:219-277
18. Reichenbach H, Höfle G(1999) Myxobacteria as producers of secondary metabolites. In: Grabley S, Thiericke R(eds) Drug discovery from nature. Springer, Berlin, pp 149-179
19. Ringel SM, Greenough RC, Roemer S, Connor D, von Strandtmann M(1977) Abruticin(W7783), a new antifungal antibiotic. J Antibiot 30:371-375
20. Shimkets L, Dworkin M, Reichenbach H(2006) The myxobacteria. In: Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E(eds) The prokaryotes, vol 7, 3rd edn. Springer, Berlin, pp 31-115
21. Singh BN(1947) Myxobacteria in soils and compost: their distribution, number and lytic action on bacteria. J Gen Microbiol 1:1-10
22. Spröer C, Reichenbach H, Stackebrandt E(1999) The correlation between morphological and phylogenetic classification of myxobacteria. Int J Syst Bacteriol 49:1255-1262
23. Stadler M, Roemer E, Müller R, Garcia RO, Pistorius D, Brachmann A(2010) Production of omega-3 fatty acids by myxobacteria. International PatentWO 2010, 063451A2
24. Warude D, Joshi K, Harsulkar A(2006) Polyunsaturated fatty acids: biotechnology. Crit Rev Biotechnol 26:83-93
25. Weissman KJ, Müller R(2009) A brief tour of myxobacterial secondary metabolism. Bioorg Med Chem 17:2121-2135
26. Weissman KJ,Müller R(2010)Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat Prod Rep 27:1276-1295
27. Wenzel SC, Müller R(2009) The biosynthetic potential of myxobacteria and their impact on drug discovery. Curr Opin Drug Discov Devel 12:220-230
28. Yarza P, Ludwig W, Euzéby J, Amann R, Schleifer K-H, Glöckner FO, Rosselló-Mó ra R(2010) Update of the all-species living-tree project based on 16S and 23S rRNA sequence analyses. Syst Appl Microbiol 33:291-299